Dynamic change of SGK expression and its role in neuron apoptosis after traumatic brain injury

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 7, 2013, Pages 1282-1293

  Wu, Xinmin ^a   Mao, Hui ^a   Liu, Jiao ^a   Xu, Jian ^a   Cao, Jianhua ^a   Gu, Xingxing ^a   Cui, Gang ^b  

^a NANTONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

GSK3 catenin signaling pathway; Neuron apoptosis; SGK; Traumatic brain injury (TBI)

Indexed keywords

BETA CATENIN; CASP3 PROTEIN, RAT; CASPASE 3; CATNB PROTEIN, RAT; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; IMMEDIATE EARLY PROTEIN; MESSENGER RNA; PROTEIN SERINE THREONINE KINASE; SERUM GLUCOCORTICOID REGULATED KINASE; SERUM-GLUCOCORTICOID REGULATED KINASE;

ANIMAL; APOPTOSIS; ARTICLE; BRAIN; BRAIN INJURY; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GSK3Β/Β-CATENIN SIGNALING PATHWAY; MALE; METABOLISM; NERVE CELL; NEURON APOPTOSIS; PATHOLOGY; PC12 CELL; PHOSPHORYLATION; RAT; RNA INTERFERENCE; SGK; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME; TRAUMATIC BRAIN INJURY (TBI); UPREGULATION;

GSK3Β/Β-CATENIN SIGNALING PATHWAY; NEURON APOPTOSIS; SGK; TRAUMATIC BRAIN INJURY (TBI);

ANIMALS; APOPTOSIS; BETA CATENIN; BRAIN; BRAIN INJURIES; CASPASE 3; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOGEN SYNTHASE KINASE 3; IMMEDIATE-EARLY PROTEINS; MALE; NEURONS; PC12 CELLS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 84882949938     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Reilly P. The impact of neurotrauma on society: an international perspective. Prog Brain Res 2007; 161: 3-9.
2. Weber JT. Altered calcium signaling following traumatic brain injury. Front Pharmacol 2012; 3: 60.
3. Kochanek PM, Clark RS, Ruppel RA, Adelson PD, Bell MJ, Whalen MJ, Robertson CL, Satchell MA, Seidberg NA, Marion DW and Jenkins LW. Biochemical, cellular, and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: Lessons learned from the bedside. Pediatr Crit Care Med 2000; 1: 4-19.
4. Loane DJ and Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 2010; 31: 596-604.
5. Hartings JA, Bullock MR, Okonkwo DO, Murray LS, Murray GD, Fabricius M, Maas AI, Woitzik J, Sakowitz O, Mathern B, Roozenbeek B, Lingsma H, Dreier JP, Puccio AM, Shutter LA, Pahl C and Strong AJ. Spreading depolarisations and outcome after traumatic brain injury: a prospective observational study. Lancet Neurol 2011; 10: 1058-1064.
6. Andriessen TM, Horn J, Franschman G, van der Naalt J, Haitsma I, Jacobs B, Steyerberg EW and Vos PE. Epidemiology, severity classification, and outcome of moderate and severe traumatic brain injury: a prospective multicenter study. J Neurotrauma 2011; 28: 2019-2031.
7. Rink A, Fung KM, Trojanowski JQ, Lee VM, Neugebauer E and McIntosh TK. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol 1995; 147: 1575-1583.
8. Hilton GD, Stoica BA, Byrnes KR and Faden AI. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. J Cereb Blood Flow Metab 2008; 28: 1845-1859.
9. Carmichael J, Sugars KL, Bao YP and Rubinsztein DC. Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation. J Biol Chem 2002; 277: 33791-33798.
10. Jin Y, Sui HJ, Dong Y, Ding Q, Qu WH, Yu SX and Jin YX. Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3beta signaling pathways. Acta Pharmacol Sin 2012; 33: 861-872.
11. Maggirwar SB, Tong N, Ramirez S, Gelbard HA and Dewhurst S. HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem 1999; 73: 578-586.
12. Tong N, Sanchez JF, Maggirwar SB, Ramirez SH, Guo H, Dewhurst S and Gelbard HA. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur J Neurosci 2001; 13: 1913-1922.
13. Hu S, Begum AN, Jones MR, Oh MS, Beech WK, Beech BH, Yang F, Chen P, Ubeda OJ, Kim PC, Davies P, Ma Q, Cole GM and Frautschy SA. GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals. Neurobiol Dis 2009; 33: 193-206.
14. Endo H, Nito C, Kamada H, Yu F and Chan PH. Akt/GSK3beta survival signaling is involved in acute brain injury after subarachnoid hemorrhage in rats. Stroke 2006; 37: 2140-2146.
15. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR and Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275: 661-665.
16. BelAiba RS, Djordjevic T, Bonello S, Artunc F, Lang F, Hess J and Gorlach A. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. Circ Res 2006; 98: 828-836.
17. Lang F, Strutz-Seebohm N, Seebohm G and Lang UE. Significance of SGK1 in the regulation of neuronal function. J Physiol 2010; 588: 3349-3354.
18. Imaizumi K, Tsuda M, Wanaka A, Tohyama M and Takagi T. Differential expression of sgk mRNA, a member of the Ser/Thr protein kinase gene family, in rat brain after CNS injury. Brain Res Mol Brain Res 1994; 26: 189-196.
19. Brunet A, Park J, Tran H, Hu LS, Hemmings BA and Greenberg ME. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 2001; 21: 952-965.
20. Logan A, Frautschy SA, Gonzalez AM and Baird A. A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury. J Neurosci 1992; 12: 3828-3837.
21. Liu Y, Wang Y, Cheng C, Chen Y, Shi S, Qin J, Xiao F, Zhou D, Lu M, Lu Q and Shen A. A relationship between p27(kip1) and Skp2 after adult brain injury: implications for glial proliferation. J Neurotrauma 2010; 27: 361-371.
22. Kaytor MD and Orr HT. The GSK3 beta signaling cascade and neurodegenerative disease. Curr Opin Neurobiol 2002; 12: 275-278.
23. Frame S and Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001; 359: 1-16.
24. Hartigan JA and Johnson GV. Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway. J Biol Chem 1999; 274: 21395-21401.
25. Jope RS and Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004; 29: 95-102.
26. Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott CW and Lee CM. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci U S A 2000; 97: 11074-11079.
27. Zhao S, Fu J, Liu X, Wang T, Zhang J and Zhao Y. Activation of Akt/GSK-3beta/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in rats. Neurol Res 2012; 34: 400-407.
28. Zhu D, Kang Q, Huang PY, He TC and Xie P. Neurogenesis-related genes expression profiling of mouse fibroblastic stem cells induced by Wnt signaling. Neurol Res 2009; 31: 200-203.
29. Polakis P. The oncogenic activation of beta-catenin. Curr Opin Genet Dev 1999; 9: 15-21.
30. Yuan J, Zhang J, Wong BW, Si X, Wong J, Yang D and Luo H. Inhibition of glycogen synthase kinase 3beta suppresses coxsackievirus-induced cytopathic effect and apoptosis via stabilization of beta-catenin. Cell Death Differ 2005; 12: 1097-1106.
31. Bhavsar SK, Merches K, Bobbala D and Lang F. AKT/SGK-sensitive phosphorylation of GSK3 in the regulation of L-selectin and perforin expression as well as activation induced cell death of T-lymphocytes. Biochem Biophys Res Commun 2012; 425: 6-12.
32. Sakoda H, Gotoh Y, Katagiri H, Kurokawa M, Ono H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Fukushima Y, Abe M, Shojima N, Kikuchi M, Oka Y, Hirai H and Asano T. Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem 2003; 278: 25802-25807.
33. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-241.
34. Park J, Leong ML, Buse P, Maiyar AC, Firestone GL and Hemmings BA. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 1999; 18: 3024-3033.
35. Leong ML, Maiyar AC, Kim B, O'Keeffe BA and Firestone GL. Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem 2003; 278: 5871-5882.
36. Schoenebeck B, Bader V, Zhu XR, Schmitz B, Lubbert H and Stichel CC. Sgk1, a cell survival response in neurodegenerative diseases. Mol Cell Neurosci 2005; 30: 249-264.
37. Siraskar B, Volkl J, Ahmed MS, Hierlmeier M, Gu S, Schmid E, Leibrock C, Foller M, Lang UE and Lang F. Enhanced catecholamine release in mice expressing PKB/SGK-resistant GSK3. Pflugers Arch 2011; 462: 811-819.
38. Foller M, Kempe DS, Boini KM, Pathare G, Siraskar B, Capuano P, Alesutan I, Sopjani M, Stange G, Mohebbi N, Bhandaru M, Ackermann TF, Judenhofer MS, Pichler BJ, Biber J, Wagner CA and Lang F. PKB/SGK-resistant GSK3 enhances phosphaturia and calciuria. J Am Soc Nephrol 2011; 22: 873-880.
39. Beurel E and Jope RS. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol 2006; 79: 173-189.
40. Hetman M, Cavanaugh JE, Kimelman D and Xia Z. Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci 2000; 20: 2567-2574.
41. Cho JH and Johnson GV. Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J Biol Chem 2004; 279: 54716-54723.
42. Chen J, Mao H, Zou H, Jin W, Ni L, Ke K, Cao M and Shi W. Up-regulation of ski-interacting protein in rat brain cortex after traumatic brain injury. J Mol Histol 2013; 44: 1-10.